{"description":"Documents matching 'part employees ensure equivalent treatment'","count":9426,"total_pages":50,"next_page_url":"https://www.federalregister.gov/api/v1/documents?conditions%5Bterm%5D=part+employees+ensure+equivalent+treatment&format=json&page=2","results":[{"title":"Performance Appraisal for General Schedule, Prevailing Rate, and Certain Other Employees","type":"Proposed Rule","abstract":"The Office of Personnel Management (OPM) is issuing a proposed rule to increase the efficiency of performance management for non- Senior Executive Service (SES) employees, including General Schedule (GS) and prevailing rate employees. The proposed rule amends the approved patterns of summary levels by removing a \"Level 2\"; requires agencies to undergo biennial appraisal system certifications with OPM; requires a supervisory critical element for all supervisors covered under this subpart; removes the prohibition of a forced, or standardized, distribution of performance-rating levels; removes the option to grieve a performance rating; and removes the mandatory review of level 1 ratings.","document_number":"2026-03619","html_url":"https://www.federalregister.gov/documents/2026/02/24/2026-03619/performance-appraisal-for-general-schedule-prevailing-rate-and-certain-other-employees","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-02-24/pdf/2026-03619.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-03619.pdf?1771854311","publication_date":"2026-02-24","agencies":[{"raw_name":"OFFICE OF PERSONNEL MANAGEMENT","name":"Personnel Management Office","id":406,"url":"https://www.federalregister.gov/agencies/personnel-management-office","json_url":"https://www.federalregister.gov/api/v1/agencies/406","parent_id":null,"slug":"personnel-management-office"}],"excerpts":"rating levels for non-SES <span class=\"match\">employees</span>. \n Non-SES <span class=\"match\">Employee</span> Performance Management \n Currently, subpart B of 5 CFR <span class=\"match\">part</span> 430 provides the requirements for managing the performance of non-SES Federal <span class=\"match\">employees</span>. 5 CFR <span class=\"match\">part</span> 430, subpart B also governs the performance appraisals of senior-level (SL) and scientific or professional (ST) <span class=\"match\">employees</span>. OPM is in the process of another rulemaking that will create a new subpart that specifically applies to SL and ST <span class=\"match\">employees</span>. Therefore, if the other rulemaking is adopted, then 5 CFR <span class=\"match\">part</span> 430, subpart B, and the changes"},{"title":"Promoting Employee Accountability","type":"Proposed Rule","abstract":"The Office of Personnel Management (OPM) and Merit Systems Protection Board (MSPB or Board) are issuing proposed regulations governing performance-based reduction in grade and removal actions, non-disciplinary separations, and adverse actions, along with the MSPB's review of those actions, and proposing improved and additional training to supervisors. With this rule, OPM seeks to improve the accountability of employees for poor performance and misconduct by streamlining the administrative procedures used by agencies to take performance-based and adverse actions; and MSPB seeks to refocus its penalty review on a totality of the circumstances test rather than a rigid application of prescribed factors. The proposed rule also promotes transparency regarding employee poor performance and misconduct by restricting agencies' ability to engage in settlement agreements that remove official documentation of performance or conduct detrimental to the efficiency of the service.","document_number":"2026-13445","html_url":"https://www.federalregister.gov/documents/2026/07/02/2026-13445/promoting-employee-accountability","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-07-02/pdf/2026-13445.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-13445.pdf?1782909924","publication_date":"2026-07-02","agencies":[{"raw_name":"OFFICE OF PERSONNEL MANAGEMENT","name":"Personnel Management Office","id":406,"url":"https://www.federalregister.gov/agencies/personnel-management-office","json_url":"https://www.federalregister.gov/api/v1/agencies/406","parent_id":null,"slug":"personnel-management-office"},{"raw_name":"MERIT SYSTEMS PROTECTION BOARD","name":"Merit Systems Protection Board","id":285,"url":"https://www.federalregister.gov/agencies/merit-systems-protection-board","json_url":"https://www.federalregister.gov/api/v1/agencies/285","parent_id":null,"slug":"merit-systems-protection-board"}],"excerpts":"from another Federal agency any information about a civilian <span class=\"match\">employee's</span> performance or conduct in that <span class=\"match\">employee's</span> official personnel records, including an <span class=\"match\">employee's</span> Official Personnel Folder and <span class=\"match\">Employee</span> Performance File, as <span class=\"match\">part</span> of, or as a condition to, resolving a formal or informal complaint by the <span class=\"match\">employee</span> or settling an administrative challenge to an adverse action. Such agreements or provisions thereof have traditionally been referred to as “clean record” settlements or become a <span class=\"match\">part</span> of agreements described as “last chance agreements.” \n 24"},{"title":"Accident Reporting: Modification to the Definition of the Term “Medical Treatment”","type":"Proposed Rule","abstract":"FMCSA proposes to amend the Federal Motor Carrier Safety Regulations (FMCSRs) to revise the term \"medical treatment\" for the purpose of accident reporting to incorporate revised regulatory guidance issued by the Agency regarding medical treatment away from the accident scene.","document_number":"2025-09732","html_url":"https://www.federalregister.gov/documents/2025/05/30/2025-09732/accident-reporting-modification-to-the-definition-of-the-term-medical-treatment","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2025-05-30/pdf/2025-09732.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2025-09732.pdf?1748376914","publication_date":"2025-05-30","agencies":[{"raw_name":"DEPARTMENT OF TRANSPORTATION","name":"Transportation Department","id":492,"url":"https://www.federalregister.gov/agencies/transportation-department","json_url":"https://www.federalregister.gov/api/v1/agencies/492","parent_id":null,"slug":"transportation-department"},{"raw_name":"Federal Motor Carrier Safety Administration","name":"Federal Motor Carrier Safety Administration","id":181,"url":"https://www.federalregister.gov/agencies/federal-motor-carrier-safety-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/181","parent_id":492,"slug":"federal-motor-carrier-safety-administration"}],"excerpts":"other imaging, such as computed tomography (CT), as medical <span class=\"match\">treatment</span>.\n \n \n FMCSA revised the guidance to clarify that a person who does not receive <span class=\"match\">treatment</span> for diagnosed injuries or other medical intervention directly related to the accident, has not received \n medical <span class=\"match\">treatment</span> \n as that term is used in §§ 390.5 or 390.5T. An x-ray or CT is not considered medical <span class=\"match\">treatment</span>. If the person were given prescription medicine or the prescription itself, that would be considered medical <span class=\"match\">treatment</span> for a diagnosed injury. FMCSA proposes to revise the definition"},{"title":"Performance Appraisal for General Schedule, Prevailing Rate, and Certain Other Employees","type":"Rule","abstract":"The Office of Personnel Management (OPM) is issuing a final rule to increase the efficiency and effectiveness of performance management for non-Senior Executive Service (SES) employees, including General Schedule (GS) and prevailing rate employees. This final rule eliminates unnecessary summary level patterns; removes the prohibition of a forced, or standardized, distribution of performance rating levels; eliminates mandatory review of Level 1 ratings; removes the option to grieve a rating of record; requires a supervisory critical element for all supervisors covered under this subpart; and requires OPM to conduct biennial certifications of agency appraisal systems.","document_number":"2026-13715","html_url":"https://www.federalregister.gov/documents/2026/07/07/2026-13715/performance-appraisal-for-general-schedule-prevailing-rate-and-certain-other-employees","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-07-07/pdf/2026-13715.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-13715.pdf?1783341917","publication_date":"2026-07-07","agencies":[{"raw_name":"OFFICE OF PERSONNEL MANAGEMENT","name":"Personnel Management Office","id":406,"url":"https://www.federalregister.gov/agencies/personnel-management-office","json_url":"https://www.federalregister.gov/api/v1/agencies/406","parent_id":null,"slug":"personnel-management-office"}],"excerpts":"does not agree that use of a standardized rating system would deny <span class=\"match\">employees</span> fair or equitable <span class=\"match\">treatment</span> or subject them to arbitrary action. The merit system principles do not prohibit agencies from rating <span class=\"match\">employees</span> based upon a comparison of individual <span class=\"match\">employee</span> performance. They instead guard against personnel decisions based on factors other than merit. Under the final rule, supervisors will continue to evaluate <span class=\"match\">employee</span> performance based on their assessments of their <span class=\"match\">employees</span>' individual performance against established performance standards"},{"title":"TRICARE Coverage of Clinical Trials and Termination of Expanded Access Treatments","type":"Rule","abstract":"The Assistant Secretary of Defense for Health Affairs (ASD(HA)) issues this final rule regarding circumstances under which services and supplies related to emerging treatments may be covered under the TRICARE program. This rule finalizes provisions published in two interim final rules (IFRs) with request for comment, which temporarily added coverage for the treatment use of investigational drugs under U.S. Food and Drug Administration (FDA)-authorized expanded access (EA) programs when for the treatment of coronavirus disease 2019 (COVID-19) and permitted coverage of National Institute of Allergy and Infectious Disease (NIAID)-sponsored clinical trials for the treatment or prevention of COVID-19. This final rule discusses the DoD's decision not to make permanent the coverage of treatment use of investigational drugs under FDA EA programs while updating language for care associated with their administration and broadens the COVID-19 clinical trial benefit to include coverage of clinical trials sponsored or approved by any National Institutes of Health (NIH) Center or Institute to treat or prevent infectious diseases associated with a pandemic or epidemic. Lastly, the final rule expands TRICARE's clinical trial benefit by covering services and supplies provided in conjunction with Phase I, II, III, and IV clinical trials that are NIH-sponsored or approved and that involve a new treatment or cure for a specific condition or the treatment of a currently uncontrolled symptom or aspect of that condition, provided that the condition is severely debilitating, life- threatening, or a rare disease.","document_number":"2025-14206","html_url":"https://www.federalregister.gov/documents/2025/07/28/2025-14206/tricare-coverage-of-clinical-trials-and-termination-of-expanded-access-treatments","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2025-07-28/pdf/2025-14206.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2025-14206.pdf?1753447522","publication_date":"2025-07-28","agencies":[{"raw_name":"DEPARTMENT OF DEFENSE","name":"Defense Department","id":103,"url":"https://www.federalregister.gov/agencies/defense-department","json_url":"https://www.federalregister.gov/api/v1/agencies/103","parent_id":null,"slug":"defense-department"},{"raw_name":"Office of the Secretary"}],"excerpts":"coverage of <span class=\"match\">treatment</span> use of investigational drugs under FDA EA programs for the <span class=\"match\">treatment</span> of COVID-19 permanent and on permanently covering the drugs for all diseases. No comments were received specific to the coverage of <span class=\"match\">treatment</span> use of investigational drugs on a permanent basis, either for the <span class=\"match\">treatment</span> of COVID-19 or for the <span class=\"match\">treatment</span> of other diseases. This final rule clarifies the DoD's decision not to add permanent coverage of investigational drugs authorized for <span class=\"match\">treatment</span> use under FDA EA programs when prescribed for the <span class=\"match\">treatment</span> of COVID-19"},{"title":"Veteran Readiness and Employment Program: Improving Development and Delivery of Individualized Rehabilitation Plans","type":"Proposed Rule","abstract":"The Department of Veterans Affairs (VA) proposes to amend the regulations pertaining to the Veteran Readiness and Employment (VR&E) Chapter 31 program to ensure the planning of rehabilitation programs for eligible veterans and dependents is based on information from current treatment providers and not individuals on a panel who never treated the veteran or dependent. Current regulations require consultation with a panel of individuals who are not involved in the direct care or treatment of the veteran or dependent. As such consultation is not statutorily required, VA proposes to eliminate this unnecessary process, which often adds avoidable delays to veterans' access to benefits, and streamline decision-making based on providers who actually know the veteran's needs.","document_number":"2026-08809","html_url":"https://www.federalregister.gov/documents/2026/05/06/2026-08809/veteran-readiness-and-employment-program-improving-development-and-delivery-of-individualized","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-05-06/pdf/2026-08809.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-08809.pdf?1777985115","publication_date":"2026-05-06","agencies":[{"raw_name":"DEPARTMENT OF VETERANS AFFAIRS","name":"Veterans Affairs Department","id":520,"url":"https://www.federalregister.gov/agencies/veterans-affairs-department","json_url":"https://www.federalregister.gov/api/v1/agencies/520","parent_id":null,"slug":"veterans-affairs-department"}],"excerpts":"amend the regulations pertaining to the Veteran Readiness and Employment (VR&amp;E) Chapter 31 program to <span class=\"match\">ensure</span> the planning of rehabilitation programs for eligible veterans and dependents is based on information from current <span class=\"match\">treatment</span> providers and not individuals on a panel who never treated the veteran or dependent. Current regulations require consultation with a panel of individuals who are not involved in the direct care or <span class=\"match\">treatment</span> of the veteran or dependent. As such consultation is not statutorily required, VA proposes to eliminate this"},{"title":"Employee or Independent Contractor Status Under the Fair Labor Standards Act, Family and Medical Leave Act, and Migrant and Seasonal Agricultural Worker Protection Act","type":"Proposed Rule","abstract":"The Department is proposing to rescind the analysis for determining employee or independent contractor status under the Fair Labor Standards Act (FLSA) currently set forth in 29 CFR part 795 and replace it with the analysis that it published and adopted in a prior final rule dated January 7, 2021, with a few modifications. In addition, the Department proposes to apply this analysis to the Family and Medical Leave Act (FMLA) and Migrant and Seasonal Agricultural Worker Protection Act (MSPA), both of which incorporate the FLSA's scope of employment.","document_number":"2026-03962","html_url":"https://www.federalregister.gov/documents/2026/02/27/2026-03962/employee-or-independent-contractor-status-under-the-fair-labor-standards-act-family-and-medical","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-02-27/pdf/2026-03962.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-03962.pdf?1772113515","publication_date":"2026-02-27","agencies":[{"raw_name":"DEPARTMENT OF LABOR","name":"Labor Department","id":271,"url":"https://www.federalregister.gov/agencies/labor-department","json_url":"https://www.federalregister.gov/api/v1/agencies/271","parent_id":null,"slug":"labor-department"},{"raw_name":"Wage and Hour Division","name":"Wage and Hour Division","id":524,"url":"https://www.federalregister.gov/agencies/wage-and-hour-division","json_url":"https://www.federalregister.gov/api/v1/agencies/524","parent_id":271,"slug":"wage-and-hour-division"}],"excerpts":"work is performed; (ii) The putative <span class=\"match\">employee's</span> opportunity for profit or loss depending upon his/her managerial skill; (iii) The putative <span class=\"match\">employee's</span> investment in equipment or materials required for the task, or the putative <span class=\"match\">employee's</span> employment of other workers; (iv) Whether the services rendered by the putative <span class=\"match\">employee</span> require special skill; (v) The degree of permanency and duration of the working relationship; (vi) The extent to which the services rendered by the putative <span class=\"match\">employee</span> are an integral <span class=\"match\">part</span> of the putative employer's business.” "},{"title":"Medicare and Medicaid Programs; CY 2026 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program","type":"Rule","abstract":"This major final rule addresses: changes to the physician fee schedule (PFS); other changes to Medicare Part B payment policies to ensure that payment systems are updated to reflect changes in medical practice, relative value of services, and changes in the statute; codification of establishment of new policies for: the Medicare Prescription Drug Inflation Rebate Program under the Inflation Reduction Act of 2022; the Ambulatory Specialty Model; updates to the Medicare Diabetes Prevention Program expanded model; updates to drugs and biological products paid under Part B; Medicare Shared Savings Program requirements; updates to the Quality Payment Program; updates to policies for Rural Health Clinics and Federally Qualified Health Centers; update to the Ambulance Fee Schedule regulations; codification of the Inflation Reduction Act and Consolidated Appropriations Act, 2023 provisions; updates to the Medicare Promoting Interoperability Program.","document_number":"2025-19787","html_url":"https://www.federalregister.gov/documents/2025/11/05/2025-19787/medicare-and-medicaid-programs-cy-2026-payment-policies-under-the-physician-fee-schedule-and-other","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2025-11-05/pdf/2025-19787.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2025-19787.pdf?1761945018","publication_date":"2025-11-05","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Centers for Medicare & Medicaid Services","name":"Centers for Medicare & Medicaid Services","id":45,"url":"https://www.federalregister.gov/agencies/centers-for-medicare-medicaid-services","json_url":"https://www.federalregister.gov/api/v1/agencies/45","parent_id":221,"slug":"centers-for-medicare-medicaid-services"}],"excerpts":"parties to submit information, such as detailed survey data, for consideration in future rulemaking to <span class=\"match\">ensure</span> accurate valuation.\n \n (4) Excimer Laser <span class=\"match\">Treatment</span> for Psoriasis (CPT Codes 96920, 96921, 96922) \n \n An interested party nominated CPT codes 96920 (\n Excimer laser <span class=\"match\">treatment</span> for psoriasis; total area less than 250 sq cm \n ), 96921 (\n Excimer laser <span class=\"match\">treatment</span> for psoriasis; 250 sq cm to 500 sq cm \n ), and 96922 (\n Excimer laser <span class=\"match\">treatment</span> for psoriasis; over 500 sq cm \n ) as potentially misvalued, due to the CPT Editorial Panel's recent modifications"},{"title":"Medicare and Medicaid Programs; CY 2025 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; Medicare Prescription Drug Inflation Rebate Program; and Medicare Overpayments","type":"Rule","abstract":"This final rule addresses: changes to the physician fee schedule (PFS); other changes to Medicare Part B payment policies to ensure that payment systems are updated to reflect changes in medical practice, relative value of services, and changes in the statute; codification of establishment of new policies for, the Medicare Prescription Drug Inflation Rebate Program under the Inflation Reduction Act of 2022; updates to the Medicare Diabetes Prevention Program expanded model; payment for dental services inextricably linked to specific covered medical services; updates to drugs and biological products paid under Part B including immunosuppressive drugs and clotting factors; Medicare Shared Savings Program requirements; updates to the Quality Payment Program; Medicare coverage of opioid use disorder services furnished by opioid treatment programs; updates to policies for Rural Health Clinics and Federally Qualified Health Centers; electronic prescribing for controlled substances for a covered Part D drug under a prescription drug plan or a Medicare Advantage Prescription Drug (MA-PD) plan under the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act (SUPPORT Act); update to the Ambulance Fee Schedule regulations; codification of the Inflation Reduction Act and Consolidated Appropriations Act, 2023 provisions; updates to Clinical Laboratory Fee Schedule regulations; updates to the diabetes payment structure and PHE flexibilities; expansion of colorectal cancer screening and Hepatitis B vaccine coverage and payment; establishing payment for drugs covered as additional preventive services; Medicare Parts A and B Overpayment Provisions of the Affordable Care Act and Medicare Parts C and D Overpayment Provisions of the Affordable Care Act.","document_number":"2024-25382","html_url":"https://www.federalregister.gov/documents/2024/12/09/2024-25382/medicare-and-medicaid-programs-cy-2025-payment-policies-under-the-physician-fee-schedule-and-other","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2024-12-09/pdf/2024-25382.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2024-25382.pdf?1730492138","publication_date":"2024-12-09","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Centers for Medicare & Medicaid Services","name":"Centers for Medicare & Medicaid Services","id":45,"url":"https://www.federalregister.gov/agencies/centers-for-medicare-medicaid-services","json_url":"https://www.federalregister.gov/api/v1/agencies/45","parent_id":221,"slug":"centers-for-medicare-medicaid-services"}],"excerpts":"they are integral to a patient's overall <span class=\"match\">treatment</span> and furnished after the <span class=\"match\">treatment</span> plan is established. The medical or direct care CTS themselves need to be congruent with the <span class=\"match\">treatment</span> plan and designed to effectuate the desired patient outcomes. We believe this is especially the case in medical <span class=\"match\">treatment</span> scenarios where assistance by the caregiver receiving the CTS is necessary to <span class=\"match\">ensure</span> a successful <span class=\"match\">treatment</span> outcome for the patient—for example when the patient cannot follow through with the <span class=\"match\">treatment</span> plan for themselves. Direct care training"},{"title":"Medicare Program; End-Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals With Acute Kidney Injury, End-Stage Renal Disease Quality Incentive Program, and End-Stage Renal Disease Treatment Choices Model","type":"Rule","abstract":"This final rule updates and revises the End-Stage Renal Disease (ESRD) Prospective Payment System for calendar year 2026. This rule also includes updates to the payment rate for renal dialysis services furnished by an ESRD facility to individuals with acute kidney injury. In addition, this rule updates the requirements for the ESRD Quality Incentive Program and terminates and modifies requirements for the ESRD Treatment Choices Model.","document_number":"2025-20681","html_url":"https://www.federalregister.gov/documents/2025/11/24/2025-20681/medicare-program-end-stage-renal-disease-prospective-payment-system-payment-for-renal-dialysis","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2025-11-24/pdf/2025-20681.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2025-20681.pdf?1763673309","publication_date":"2025-11-24","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Centers for Medicare & Medicaid Services","name":"Centers for Medicare & Medicaid Services","id":45,"url":"https://www.federalregister.gov/agencies/centers-for-medicare-medicaid-services","json_url":"https://www.federalregister.gov/api/v1/agencies/45","parent_id":221,"slug":"centers-for-medicare-medicaid-services"}],"excerpts":"non-labor cost per <span class=\"match\">treatment</span> as the dependent variable. As cost report data includes both Medicare and non-Medicare dialysis <span class=\"match\">treatments</span> and costs, this analysis also encompassed all <span class=\"match\">treatments</span> furnished by ESRD facilities. We controlled for various facility-level characteristics including log quadratic facility <span class=\"match\">treatment</span> volume, rurality, wage index value, ownership-type, percent of <span class=\"match\">treatments</span> which are Medicare <span class=\"match\">treatments</span>, percent of <span class=\"match\">treatments</span> which are home dialysis <span class=\"match\">treatments</span>, average case-mix adjustment multiplier for Medicare <span class=\"match\">treatments</span>, an indicator"},{"title":"Drug and Alcohol Clearinghouse Requirements; Driver Qualification Requirements: Waste Management Holdings, Inc.; Application for Exemptions","type":"Notice","abstract":"FMCSA announces its decision to grant in part and deny in part the exemption application from Waste Management Holdings, Inc. (WM) for a period of two years. FMCSA grants WM's request for limited relief from certain driver qualification requirements to allow WM to use the exception for a \"single-employer driver\" when it transfers drivers among affiliates. FMCSA also grants a limited exemption from the requirement for the driver to undergo controlled substances testing when being transferred among affiliates if the driver has participated in a WM random controlled substances testing pool for any WM-affiliated employer for the previous 12 months. Finally, FMCSA grants an exemption to allow WM to conduct a limited, rather than full, Clearinghouse query when transferring drivers among affiliates. FMCSA denies WM's request for broad exemptions from the pre-employment controlled substance testing and Clearinghouse requirements. FMCSA concludes that the exemptions will likely achieve a level of safety equivalent to or greater than the level of safety that would be achieved absent the exemptions.","document_number":"2026-09469","html_url":"https://www.federalregister.gov/documents/2026/05/13/2026-09469/drug-and-alcohol-clearinghouse-requirements-driver-qualification-requirements-waste-management","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-05-13/pdf/2026-09469.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-09469.pdf?1778589911","publication_date":"2026-05-13","agencies":[{"raw_name":"DEPARTMENT OF TRANSPORTATION","name":"Transportation Department","id":492,"url":"https://www.federalregister.gov/agencies/transportation-department","json_url":"https://www.federalregister.gov/api/v1/agencies/492","parent_id":null,"slug":"transportation-department"},{"raw_name":"Federal Motor Carrier Safety Administration","name":"Federal Motor Carrier Safety Administration","id":181,"url":"https://www.federalregister.gov/agencies/federal-motor-carrier-safety-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/181","parent_id":492,"slug":"federal-motor-carrier-safety-administration"}],"excerpts":"affiliated motor carriers must comply with all other applicable FMCSRs (49 CFR parts 350-399). \n 2. WM and its affiliated motor carriers must <span class=\"match\">ensure</span> that no <span class=\"match\">employee</span> drives a CMV until he or she is qualified to drive a CMV under 49 CFR 391.11. \n 3. WM and its affiliated motor carriers must <span class=\"match\">ensure</span> that no driver subject to 49 CFR <span class=\"match\">part</span> 382 operates a CMV when he or she is not compliant with the requirements in <span class=\"match\">part</span> 382. \n 4. All affiliated motor carriers must be enrolled in, and actively participating in, WM's Employment Screening Program and its licensing"},{"title":"Drug and Alcohol Testing of Certificated Repair Station Employees Located Outside of the United States","type":"Rule","abstract":"This final rule requires certificated repair stations located outside the territory of the United States (U.S.) whose employees perform safety-sensitive maintenance functions on certain air carrier aircraft to conduct alcohol and controlled substance testing in a manner acceptable to the Administrator and consistent with the applicable laws of the country in which the repair station is located. The final rule directs the repair station to comply with the requirements of the Drug and Alcohol Testing Program published by the FAA and the Procedures for Transportation Workplace Drug Testing Programs published by the Department of Transportation, as proposed. However, this final rule also allows foreign governments, on behalf of certificated repair stations within their territories, and individual foreign repair stations subject to the rule to obtain the Administrator's recognition of a compatible alternative that contains minimum criteria in lieu of compliance with certain components of the Drug and Alcohol Testing Program.","document_number":"2024-29837","html_url":"https://www.federalregister.gov/documents/2024/12/18/2024-29837/drug-and-alcohol-testing-of-certificated-repair-station-employees-located-outside-of-the-united","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2024-12-18/pdf/2024-29837.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2024-29837.pdf?1734356753","publication_date":"2024-12-18","agencies":[{"raw_name":"DEPARTMENT OF TRANSPORTATION","name":"Transportation Department","id":492,"url":"https://www.federalregister.gov/agencies/transportation-department","json_url":"https://www.federalregister.gov/api/v1/agencies/492","parent_id":null,"slug":"transportation-department"},{"raw_name":"Federal Aviation Administration","name":"Federal Aviation Administration","id":159,"url":"https://www.federalregister.gov/agencies/federal-aviation-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/159","parent_id":492,"slug":"federal-aviation-administration"}],"excerpts":"that contains minimum elements of 14 CFR <span class=\"match\">part</span> 120.\n \n Affected foreign repair stations that receive a waiver based on recognition by the Administrator will be relieved from comprehensive compliance with subparts E and F of 14 CFR <span class=\"match\">part</span> 120 (in turn, providing relief from 49 CFR <span class=\"match\">part</span> 40) and will not need to seek further waivers or exemptions from 14 CFR <span class=\"match\">part</span> 120 or 49 CFR <span class=\"match\">part</span> 40 under this final rule. All other foreign repair stations subject to the rule will be required to meet 14 CFR <span class=\"match\">part</span> 120 and 49 CFR <span class=\"match\">part</span> 40, subject to any waivers or exemptions"},{"title":"Ensuring Safe Accommodations for Air Travelers With Disabilities Using Wheelchairs","type":"Rule","abstract":"The U.S. Department of Transportation (DOT or the Department) is issuing a final rule to strengthen its regulation implementing the Air Carrier Access Act (ACAA) and to address the serious problems that individuals with disabilities using wheelchairs and scooters face when traveling by air that impact their safety and dignity, including mishandled wheelchairs and scooters and improper transfers to and from aircraft seats, aisle chairs, and personal wheelchairs. This final rule also carries out certain rulemaking provisions required by the FAA Reauthorization Act of 2024.","document_number":"2024-29731","html_url":"https://www.federalregister.gov/documents/2024/12/17/2024-29731/ensuring-safe-accommodations-for-air-travelers-with-disabilities-using-wheelchairs","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2024-12-17/pdf/2024-29731.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2024-29731.pdf?1734356740","publication_date":"2024-12-17","agencies":[{"raw_name":"DEPARTMENT OF TRANSPORTATION","name":"Transportation Department","id":492,"url":"https://www.federalregister.gov/agencies/transportation-department","json_url":"https://www.federalregister.gov/api/v1/agencies/492","parent_id":null,"slug":"transportation-department"},{"raw_name":"Office of the Secretary"}],"excerpts":"handling form(s) that may exist, to <span class=\"match\">ensure</span> the safe and proper handling of such assistive devices. \n Under the NPRM's proposal, “hands-on training” was defined as training that is received by an <span class=\"match\">employee</span> or contractor where the <span class=\"match\">employee</span> or contractor performs a task, function, or procedure that would be <span class=\"match\">part</span> of his or her normal duties in a controlled/simulated environment and with the use of a suitable life-sized model or equipment, as appropriate. \n As for training frequency, these covered airline <span class=\"match\">employees</span> and contractors would need to be initially"},{"title":"Elimination of Time-in-Grade","type":"Proposed Rule","abstract":"The Office of Personnel Management (OPM) proposes eliminating the Time-in-Grade (TIG) restriction on advancement to competitive service positions in the General Schedule. Currently, employees in competitive service General Schedule positions in grades 5 and above must serve 52 weeks in grade before becoming eligible for promotion to the next grade level. Abolishing the restriction would eliminate the 52-week service requirement. If the requirement is eliminated, an employee must continue to meet occupational qualification standard requirements, and any additional job-related qualification requirements.","document_number":"2026-10552","html_url":"https://www.federalregister.gov/documents/2026/05/28/2026-10552/elimination-of-time-in-grade","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-05-28/pdf/2026-10552.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-10552.pdf?1779885909","publication_date":"2026-05-28","agencies":[{"raw_name":"OFFICE OF PERSONNEL MANAGEMENT","name":"Personnel Management Office","id":406,"url":"https://www.federalregister.gov/agencies/personnel-management-office","json_url":"https://www.federalregister.gov/api/v1/agencies/406","parent_id":null,"slug":"personnel-management-office"}],"excerpts":"Federal <span class=\"match\">Employees</span>. \n TIG applies to competitive service General Schedule (GS) <span class=\"match\">employees</span> but does not apply to competitive service <span class=\"match\">employees</span> under other pay plans, including <span class=\"match\">employees</span> in Wage Grade positions. TIG does not apply to those competitive service GS <span class=\"match\">employees</span> who apply for other competitive service positions through a competitive examination. The TIG restriction does not apply to excepted service GS <span class=\"match\">employees</span>, although individual agencies can, at their discretion, require TIG for their excepted service <span class=\"match\">employees</span>. This disparate <span class=\"match\">treatment</span> of"},{"title":"Medicare and Medicaid Programs; CY 2026 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program","type":"Proposed Rule","abstract":"This major proposed rule addresses: changes to the physician fee schedule (PFS); other changes to Medicare Part B payment policies to ensure that payment systems are updated to reflect changes in medical practice, relative value of services, and changes in the statute; codification of establishment of new policies for: the Medicare Prescription Drug Inflation Rebate Program under the Inflation Reduction Act of 2022; the Ambulatory Specialty Model; updates to the Medicare Diabetes Prevention Program expanded model; updates to drugs and biological products paid under Part B; Medicare Shared Savings Program requirements; updates to the Quality Payment Program; updates to policies for Rural Health Clinics and Federally Qualified Health Centers update to the Ambulance Fee Schedule regulations; codification of the Inflation Reduction Act and Consolidated Appropriations Act, 2023 provisions; updates to the Medicare Promoting Interoperability Program.","document_number":"2025-13271","html_url":"https://www.federalregister.gov/documents/2025/07/16/2025-13271/medicare-and-medicaid-programs-cy-2026-payment-policies-under-the-physician-fee-schedule-and-other","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2025-07-16/pdf/2025-13271.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2025-13271.pdf?1752524111","publication_date":"2025-07-16","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Centers for Medicare & Medicaid Services","name":"Centers for Medicare & Medicaid Services","id":45,"url":"https://www.federalregister.gov/agencies/centers-for-medicare-medicaid-services","json_url":"https://www.federalregister.gov/api/v1/agencies/45","parent_id":221,"slug":"centers-for-medicare-medicaid-services"}],"excerpts":"payment amount benchmark quarter in certain instances and the calculation for the <span class=\"match\">Part</span> B rebate amount in such instances. With respect to the Medicare <span class=\"match\">Part</span> D Drug Inflation Rebate Program, this rulemaking proposes to clarify the calculation of a <span class=\"match\">Part</span> D rebate amount, and proposes a methodology for removal of units for a <span class=\"match\">Part</span> D rebatable drug for which a manufacturer provides a discount under the 340B Program, as well as the establishment of a 340B data repository for <span class=\"match\">Part</span> D claims. \n This rulemaking proposes to modify policies for the Shared Savings"},{"title":"Regulations To Address Margin Adequacy and To Account for the Treatment of Separate Accounts by Futures Commission Merchants","type":"Rule","abstract":"The Commodity Futures Trading Commission (Commission or CFTC) is amending its regulations, adopted under the Commodity Exchange Act (CEA), to require a futures commission merchant (FCM) to ensure a customer does not withdraw funds from its account with the FCM if the balance in the account after the withdrawal would be insufficient to meet the customer's initial margin requirements; and relatedly, to permit an FCM, subject to certain requirements, to treat the separate accounts of a single customer as accounts of separate entities for purposes of certain Commission regulations.","document_number":"2024-31177","html_url":"https://www.federalregister.gov/documents/2025/01/22/2024-31177/regulations-to-address-margin-adequacy-and-to-account-for-the-treatment-of-separate-accounts-by","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2025-01-22/pdf/2024-31177.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2024-31177.pdf?1736889332","publication_date":"2025-01-22","agencies":[{"raw_name":"COMMODITY FUTURES TRADING COMMISSION","name":"Commodity Futures Trading Commission","id":77,"url":"https://www.federalregister.gov/agencies/commodity-futures-trading-commission","json_url":"https://www.federalregister.gov/api/v1/agencies/77","parent_id":null,"slug":"commodity-futures-trading-commission"}],"excerpts":"contended that the Commission should codify the no-action position in its <span class=\"match\">part</span> 1 FCM regulations (where it would apply directly to all FCMs) rather than in its <span class=\"match\">part</span> 39 DCO regulations (where it would apply only to clearing FCMs, through the instrumentality of DCO rules). Other commenters did not opine on whether the proposed codification should be in <span class=\"match\">part</span> 1 versus <span class=\"match\">part</span> 39.\n \n \n \n 47 \n  Derivatives Clearing Organization Risk Management Regulations to Account for the <span class=\"match\">Treatment</span> of Separate Accounts by Futures Commission Merchants, 88 FR 39205 (June 15"},{"title":"Certification of Signal Employees","type":"Rule","abstract":"FRA is prescribing regulations for certification of signal employees, pursuant to the authority granted in section 402 of the Rail Safety Improvement Act of 2008 (RSIA).","document_number":"2024-09958","html_url":"https://www.federalregister.gov/documents/2024/05/21/2024-09958/certification-of-signal-employees","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2024-05-21/pdf/2024-09958.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2024-09958.pdf?1716209114","publication_date":"2024-05-21","agencies":[{"raw_name":"DEPARTMENT OF TRANSPORTATION","name":"Transportation Department","id":492,"url":"https://www.federalregister.gov/agencies/transportation-department","json_url":"https://www.federalregister.gov/api/v1/agencies/492","parent_id":null,"slug":"transportation-department"},{"raw_name":"Federal Railroad Administration","name":"Federal Railroad Administration","id":185,"url":"https://www.federalregister.gov/agencies/federal-railroad-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/185","parent_id":492,"slug":"federal-railroad-administration"}],"excerpts":"certification programs for conductors and to <span class=\"match\">ensure</span> that all certified conductors satisfy minimum Federal safety standards.\n 6 \n \n The conductor certification rule, published in 49 CFR <span class=\"match\">part</span> 242 (<span class=\"match\">part</span> 242), was largely modeled after <span class=\"match\">part</span> 240 with some deviations based on the different job classifications. <span class=\"match\">Part</span> 242 also included some organizational improvements which made the regulation more streamlined than <span class=\"match\">part</span> 240.\n \n \n \n 6 \n  76 FR 69801 (Nov. 9, 2011).\n \n \n C. Statutory Background for Signal <span class=\"match\">Employee</span> Certification \n In addition to requiring certification"},{"title":"Medicare Program; End-Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals With Acute Kidney Injury, End-Stage Renal Disease Quality Incentive Program, and End-Stage Renal Disease Treatment Choices Model","type":"Proposed Rule","abstract":"This proposed rule would update and revise the End-Stage Renal Disease (ESRD) Prospective Payment System for calendar year 2026. This rule also proposes to update the payment rate for renal dialysis services furnished by an ESRD facility to individuals with acute kidney injury. In addition, this rule proposes to update requirements for the ESRD Quality Incentive Program and to terminate and modify requirements for the ESRD Treatment Choices Model.","document_number":"2025-12368","html_url":"https://www.federalregister.gov/documents/2025/07/02/2025-12368/medicare-program-end-stage-renal-disease-prospective-payment-system-payment-for-renal-dialysis","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2025-07-02/pdf/2025-12368.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2025-12368.pdf?1751314516","publication_date":"2025-07-02","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Centers for Medicare & Medicaid Services","name":"Centers for Medicare & Medicaid Services","id":45,"url":"https://www.federalregister.gov/agencies/centers-for-medicare-medicaid-services","json_url":"https://www.federalregister.gov/api/v1/agencies/45","parent_id":221,"slug":"centers-for-medicare-medicaid-services"}],"excerpts":"non-labor cost per <span class=\"match\">treatment</span> as the dependent variable. As cost report data includes both Medicare and non-Medicare dialysis <span class=\"match\">treatments</span> and costs, this analysis also encompasses all <span class=\"match\">treatments</span> furnished by ESRD facilities. We controlled for various facility-level characteristics including log quadratic facility <span class=\"match\">treatment</span> volume, rurality, wage index value, ownership-type, percent of <span class=\"match\">treatments</span> which are Medicare <span class=\"match\">treatments</span>, percent of <span class=\"match\">treatments</span> which are home dialysis <span class=\"match\">treatments</span>, average case-mix adjustment multiplier for Medicare <span class=\"match\">treatments</span>, an indicator"},{"title":"Medicare and Medicaid Programs; CY 2025 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; Medicare Prescription Drug Inflation Rebate Program; and Medicare Overpayments","type":"Proposed Rule","abstract":"This major proposed rule addresses: changes to the physician fee schedule (PFS); other changes to Medicare Part B payment policies to ensure that payment systems are updated to reflect changes in medical practice, relative value of services, and changes in the statute; codification of, and proposing policies for, the Medicare Prescription Drug Inflation Rebate Program under the Inflation Reduction Act of 2022; updates to the Medicare Diabetes Prevention Program expanded model; payment for dental services inextricably linked to specific covered medical services; updates to drugs and biological products paid under Part B including immunosuppressive drugs and clotting factors; Medicare Shared Savings Program requirements; updates to the Quality Payment Program; Medicare coverage of opioid use disorder services furnished by opioid treatment programs; updates to policies for Rural Health Clinics and Federally Qualified Health Centers; electronic prescribing for controlled substances for a covered Part D drug under a prescription drug plan or a Medicare Advantage Prescription Drug (MA-PD) plan under the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act (SUPPORT Act); update to the Ambulance Fee Schedule regulations; codification of the Inflation Reduction Act and Consolidated Appropriations Act, 2023 provisions; updates to Clinical Laboratory Fee Schedule regulations; updates to the diabetes payment structure and PHE flexibilities; expansion of colorectal cancer screening and Hepatitis B vaccine coverage and payment; establishing payment for drugs covered as additional preventive services; Medicare Parts A and B Overpayment Provisions of the Affordable Care Act.","document_number":"2024-14828","html_url":"https://www.federalregister.gov/documents/2024/07/31/2024-14828/medicare-and-medicaid-programs-cy-2025-payment-policies-under-the-physician-fee-schedule-and-other","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2024-07-31/pdf/2024-14828.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2024-14828.pdf?1720642528","publication_date":"2024-07-31","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Centers for Medicare & Medicaid Services","name":"Centers for Medicare & Medicaid Services","id":45,"url":"https://www.federalregister.gov/agencies/centers-for-medicare-medicaid-services","json_url":"https://www.federalregister.gov/api/v1/agencies/45","parent_id":221,"slug":"centers-for-medicare-medicaid-services"}],"excerpts":"they are integral to a patient's overall <span class=\"match\">treatment</span> and furnished after the <span class=\"match\">treatment</span> plan is established. The medical or direct care CTS themselves need to be congruent with the <span class=\"match\">treatment</span> plan and designed to effectuate the desired patient outcomes. We believe this is especially the case in medical <span class=\"match\">treatment</span> scenarios where assistance by the caregiver receiving the CTS is necessary to <span class=\"match\">ensure</span> a successful <span class=\"match\">treatment</span> outcome for the patient—for example when the patient cannot follow through with the <span class=\"match\">treatment</span> plan for themselves. Direct care training"},{"title":"Managing Senior Professional Performance","type":"Proposed Rule","abstract":"The Office of Personnel Management (OPM) and the Office of Management and Budget (OMB) are proposing to revise the rules governing the performance appraisal of senior-level (SL) and scientific or professional (ST) employees, collectively referred to as \"senior professionals.\" This rulemaking would establish a new subpart specifically dedicated to senior professional performance appraisal. The new subpart would align more closely with the SES performance appraisal regulations, eliminate senior professional appraisal programs, remove the prohibition of a forced distribution of performance rating levels, and enhance oversight.","document_number":"2026-03610","html_url":"https://www.federalregister.gov/documents/2026/02/24/2026-03610/managing-senior-professional-performance","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-02-24/pdf/2026-03610.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-03610.pdf?1771854310","publication_date":"2026-02-24","agencies":[{"raw_name":"OFFICE OF PERSONNEL MANAGEMENT","name":"Personnel Management Office","id":406,"url":"https://www.federalregister.gov/agencies/personnel-management-office","json_url":"https://www.federalregister.gov/api/v1/agencies/406","parent_id":null,"slug":"personnel-management-office"},{"raw_name":"OFFICE OF MANAGEMENT AND BUDGET","name":"Management and Budget Office","id":280,"url":"https://www.federalregister.gov/agencies/management-and-budget-office","json_url":"https://www.federalregister.gov/api/v1/agencies/280","parent_id":null,"slug":"management-and-budget-office"}],"excerpts":"proposed subpart would be added. \n <span class=\"match\">Part</span> 1330 \n The regulations at 5 CFR <span class=\"match\">part</span> 1330, subpart D, are parallel regulations to 5 CFR <span class=\"match\">part</span> 430 subpart D, which govern the performance appraisal system certification requirements for the SES and senior professionals. Performance appraisal system certification is co-regulated by OPM and OMB and, therefore, conforming amendments to 5 CFR <span class=\"match\">part</span> 1330, subpart D, would be made identical to the changes to 5 CFR <span class=\"match\">part</span> 430, subpart D, described above. \n Editorial Corrections \n As a <span class=\"match\">part</span> of this rulemaking, OPM is proposing"}]}